Gene: NBEAL2
Official Full Name: neurobeachin like 2provided by HGNC
Gene Summary: The protein encoded by this gene contains a beige and Chediak-Higashi (BEACH) domain and multiple WD40 domains, and may play a role in megakaryocyte alpha-granule biogenesis. Mutations in this gene are a cause of gray platelet syndrome. [provided by RefSeq, Dec 2011]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO29695 | NBEAL2 Knockout cell line (HeLa) | Human | NBEAL2 | 1:3~1:6 | Negative | Online Inquiry |
KO29696 | NBEAL2 Knockout cell line (HCT 116) | Human | NBEAL2 | 1:2~1:4 | Negative | Online Inquiry |
KO29697 | NBEAL2 Knockout cell line (HEK293) | Human | NBEAL2 | 1:3~1:6 | Negative | Online Inquiry |
KO29698 | NBEAL2 Knockout cell line (A549) | Human | NBEAL2 | 1:3~1:4 | Negative | Online Inquiry |
NBEAL2 Gene Knockout Cell Lines represent a cutting-edge advancement in genetic research, specifically designed to facilitate the study of NBEAL2 gene function and its roles in cellular processes. These specialized cell lines have been genetically engineered to produce a complete knockout of the NBEAL2 gene, allowing researchers to investigate the effects of its absence in various biological contexts, including disease modeling and therapeutic development.
The primary function of NBEAL2 Gene Knockout Cell Lines is to enable comprehensive analyses of the cellular mechanisms modulated by the NBEAL2 protein, which is implicated in functions such as platelet biogenesis and regulation of hemostasis. By utilizing CRISPR/Cas9 technology, these cell lines permit precise and efficient gene editing, resulting in a complete loss-of-function phenotype that researchers can leverage to explore downstream signaling pathways and identify potential compensation mechanisms.
The scientific importance of these cell lines is underscored by their potential applications in research and clinical settings. NBEAL2 is associated with various hematological disorders, including familial macrothrombocytopenia. Through the use of these knockout cell lines, scientists can elucidate the molecular pathways affected by NBEAL2 deficiency, paving the way for novel therapeutic approaches and targeted interventions in related diseases.
Compared to traditional methods of gene disruption, NBEAL2 Gene Knockout Cell Lines offer several advantages. They provide a standardized model that enhances reproducibility and facilitates high-throughput screening of potential therapeutics. Moreover, these cell lines can help uncover functional insights that might be obscured in systems with residual gene expression, thus delivering a clearer picture of NBEAL2's role in pathophysiology.
For researchers and clinicians, the value of NBEAL2 Gene Knockout Cell Lines is clear: they not only streamline the research process but also foster innovative discoveries that could lead to significant improvements in patient care. By investing in these advanced cell lines, users are better positioned to explore vital biological questions and accelerate the development of new treatment modalities.
Our company brings a wealth of expertise in genetic engineering and a commitment to providing high-quality biological products. With a focus on innovation and scientific rigor, we are dedicated to supporting your research endeavors and advancing the field of molecular biology.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.